Calcium Chloride Injection
NDC Package 76329-3304-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Calcium Chloride injection is uSP, 10% is indicated:In the treatment of hypocalcemia in conditions requiring a prompt increase in plasma calcium levels (e.g., neonatal tetany and tetany due to parathyroid deficiency, vitamin D deficiency and alkalosis) and for prevention of hypocalcemia during exchange transfusions.As adjunctive therapy in the management of acute symptoms in lead colic.In the treatment of magnesium intoxication due to overdosage of magnesium sulfate.In severe hyperkalemia, to combat deleterious effects on electrocardiographic (ECG) function, pending correction of the potassium level in the extracellular fluid.In cardiac resuscitation, particularly after open heart surgery, when epinephrine fails to improve weak or ineffective myocardial contractions. This formulation utilizes a injection delivery system. Marketed by International Medication Systems, Limited, this product is identified by NDC 76329-3304 and is authorized under FDA application ANDA203477.

Identification & Billing

NDC Package Code
76329-3304-1
Package Description
10 SYRINGE in 1 PACKAGE / 10 mL in 1 SYRINGE
Product Code
76329-3304
11-Digit Billing Format
76329330401
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 828527 - calcium chloride 10 % in 10 ML Prefilled Syringe
  • RxCUI: 828527 - 10 ML calcium chloride 100 MG/ML Prefilled Syringe

Clinical Specifications

Proprietary Name
Calcium Chloride
Non-Proprietary Name
Calcium Chloride
Substance Name
Calcium Chloride
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
  • Intravenous - Administration within or into a vein or veins.
  • Intraventricular - Administration within a ventricle.
Active Ingredient(s)
CALCIUM CHLORIDE 100 mg/mL
Pharmacologic Class
Usage Information
Calcium Chloride Injection, USP, 10% is indicated:In the treatment of hypocalcemia in conditions requiring a prompt increase in plasma calcium levels (e.g., neonatal tetany and tetany due to parathyroid deficiency, vitamin D deficiency and alkalosis) and for prevention of hypocalcemia during exchange transfusions.As adjunctive therapy in the management of acute symptoms in lead colic.In the treatment of magnesium intoxication due to overdosage of magnesium sulfate.In severe hyperkalemia, to combat deleterious effects on electrocardiographic (ECG) function, pending correction of the potassium level in the extracellular fluid.In cardiac resuscitation, particularly after open heart surgery, when epinephrine fails to improve weak or ineffective myocardial contractions.

Regulatory & Marketing

Labeler Name
International Medication Systems, Limited
Product Type
Human Prescription Drug
FDA Application #
ANDA203477
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-08-2018
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 76329-3304-1 identifies a specific commercial package of 10 syringe in 1 package / 10 ml in 1 syringe of Calcium Chloride, a human prescription drug labeled by International Medication Systems, Limited. This injection is formulated for intravenous; intraventricular use and contains calcium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by International Medication Systems, Limited on July 08, 2018. The current certification is valid through December 31, 2026.

How is this International Medication Systems, Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 76329330401. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
76329-3304-1
11-Digit CMS (5-4-2)
76329-3304-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.